Pregnancy outcomes in women with moderate-to-severe psoriasis
- PMID: 21108670
- DOI: 10.1111/j.1468-3083.2010.03917.x
Pregnancy outcomes in women with moderate-to-severe psoriasis
Abstract
Background: The association between psoriasis and pregnancy outcomes has not been adequately examined, although psoriasis onset is common in the reproductive period.
Objective: To evaluate the association between moderate-to-severe psoriasis and pregnancy complications.
Methods: A retrospective, matched cohort study of 68 deliveries in 35 women with moderate-to-severe psoriasis compared to 237 deliveries in 236 women without psoriasis randomly selected after matching for age, parity and gestational age.
Results: The psoriasis patients had higher mean of past spontaneous (0.42±0.58 vs. 0.26±0.63, P=0.002) and induced (0.32±0.60 vs. 0.06±0.25, P=0.001) abortions than controls. They had a higher percentage of pregnancy-induced hypertensive diseases (7.4% vs. 2.1%, P<0.05) and premature rupture of membranes (16% vs. 5.5%, P<0.008). Newborns to women with psoriasis had higher birth weight (3375±543 g vs. 3247±460 g, P=0.03), increased percentage of large-for-gestational age (24% vs. 12%, P=0.02), and macrosomia (13% vs. 4.2%P=0.02). In multivariate analysis, moderate-to-severe psoriasis was an independent risk factor for previous spontaneous abortions, induced abortions, premature rupture of membranes (PROM), and newborn macrosomia.
Conclusion: Moderate-to-severe psoriasis is associated with spontaneous and induced abortions, pregnancy-induced hypertensive diseases, premature rupture of membranes, large-for-gestational age newborns, and macrosomia.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
Similar articles
-
Pregnancy outcome following recurrent spontaneous abortions.Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):61-5. doi: 10.1016/j.ejogrb.2004.06.015. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 15596274
-
Pregnancy outcome in women with psoriasis.J Reprod Med. 2008 Mar;53(3):183-7. J Reprod Med. 2008. PMID: 18441722
-
Perinatal outcomes in women with preterm rupture of membranes between 24 and 32 weeks of gestation and a history of vaginal bleeding.Am J Obstet Gynecol. 2005 Jul;193(1):164-8. doi: 10.1016/j.ajog.2004.10.625. Am J Obstet Gynecol. 2005. PMID: 16021074
-
Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives.G Ital Dermatol Venereol. 2019 Jun;154(3):305-314. doi: 10.23736/S0392-0488.18.06255-7. G Ital Dermatol Venereol. 2019. PMID: 31001966 Review.
-
State-of-the-Art Review of Pregnancy-Related Psoriasis.Medicina (Kaunas). 2021 Aug 5;57(8):804. doi: 10.3390/medicina57080804. Medicina (Kaunas). 2021. PMID: 34441010 Free PMC article. Review.
Cited by
-
Therapy of PsO in Special Subsets of Patients.Biomedicines. 2022 Nov 10;10(11):2879. doi: 10.3390/biomedicines10112879. Biomedicines. 2022. PMID: 36359399 Free PMC article. Review.
-
Impact of Psoriasis on Pregnancy Desire and Possible Consequences on Fertility.Dermatol Pract Concept. 2024 Oct 30;14(4):e2024221. doi: 10.5826/dpc.1404a221. Dermatol Pract Concept. 2024. PMID: 39652941 Free PMC article.
-
Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?Front Immunol. 2014 May 19;5:231. doi: 10.3389/fimmu.2014.00231. eCollection 2014. Front Immunol. 2014. PMID: 24904581 Free PMC article. Review.
-
Spontaneous abortion during ustekinumab therapy.J Dermatol Case Rep. 2012 Dec 31;6(4):105-7. doi: 10.3315/jdcr.2012.1116. J Dermatol Case Rep. 2012. PMID: 23329988 Free PMC article.
-
[Psoriasis therapy in pregnancy : Consultation of pregnant patients].Hautarzt. 2019 Dec;70(12):969-974. doi: 10.1007/s00105-019-4444-2. Hautarzt. 2019. PMID: 31218417 German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous